Neurobiology of Type 2 Diabetes
- 1st Edition - June 1, 2026
- Latest edition
- Editors: Shovit Ranjan, Sandeep Kumar Singh, Burkhard Poeggeler
- Language: English
The "Neurobiology of Type 2 Diabetes" delves into the intricate interplay between the nervous system and the development, progression, and management of Type 2 Diabetes. This… Read more
- Explores the neurobiology of glucose homeostasis and insulin resistance
- Examines the neural circuits and neuroendocrine regulation involved in metabolic control
- Details the clinical manifestations, diagnostic approaches, and management of diabetic neuropathy
- Presents case studies highlighting clinical decision-making and outcomes
- Reviews the current and emerging therapeutics for type 2 diabetes
2. Neural Regulation of Glucose Homeostasis
3. Neuroinflammation and Insulin Resistance
4. Neurological Complications of Type 2 Diabetes
5. Brain-Gut Axis in Metabolic Control
6. Neuroendocrine Regulation of Metabolism
7. Emerging Therapeutic Approaches in Neurobiology of Type 2 Diabetes
8. Case Studies: Applying Neurobiology in Clinical Practice
9. Future Directions and Challenges
10. Conclusion and Summary
- Edition: 1
- Latest edition
- Published: June 1, 2026
- Language: English
SR
Shovit Ranjan
SS
Sandeep Kumar Singh
Dr. Sandeep Kumar Singh is Assistant Professor in the All India Institute of Medical Sciences (AIIMS), Nagpur, India. He obtained his PhD in Biotechnology from Banaras Hindu University and conducted postdoctoral research in the Department of Neurobiology at the University of Chicago. Dr. Singh brings 17 years of experience in neuroscience, molecular biology, neurodegenerative diseases, aging, nutraceuticals, and nanomedicines. He is a member of several scientific societies, including the American Academy of Neurology, International Society of Neurochemistry, Society of Neurochemistry, Indian Academy of Neurosciences, and Alzheimer’s and related Disorders Society of India. Dr. Singh has published five books, including Elsevier’s A New Era in Alzheimer’s Research and Genome Editing for Neurodegenerative Diseases.
BP